Skip to content

Clinical trials

Phase 2 Lymphoma, Mantle-Cell trials in Germany

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lymphoma, Mantle-Cell Phase: Phase 2 Country / region: Germany Clear all

16 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20043
20051
20082
20091
20111
20132
20151
20171
20191
20211
20221
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed11
Active, not recruiting2
Recruiting1
Terminated1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Celgene2
Eli Lilly and Company2
Kite, A Gilead Company2
Christian Schmidt, MD1
European Organisation for Research and Treatment of Cancer - EORTC1
Fred Hutchinson Cancer Center1
Heidelberg University1
Incyte Corporation1
Merck Sharp & Dohme LLC1
Novartis Pharmaceuticals1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lymphoma, Mantle-Cell16
Lymphoma, Non-Hodgkin7
Lymphoma, Follicular5
Lymphoma4
Lymphoma, Large B-Cell, Diffuse4
Leukemia, Lymphocytic, Chronic, B-Cell3
Lymphoma, B-Cell, Marginal Zone3
Blast Crisis2
Burkitt Lymphoma2
Hodgkin Disease2

Trials

Showing 1 to 16 of 16. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.